Stay updated on Olpasiran Study: Clinical Trial for Lipoprotein(a) Reduction
Sign up to get notified when there's something new on the Olpasiran Study: Clinical Trial for Lipoprotein(a) Reduction page.

Latest updates to the Olpasiran Study: Clinical Trial for Lipoprotein(a) Reduction page
- Check3 days agoChange DetectedExpanded the study location data with numerous regional and country locations (e.g., California, Florida, Georgia, Kansas, Maryland, New York, North Carolina, Ohio, Texas; New South Wales, Queensland, Victoria, Western Australia; Ontario, Quebec; Chiba, Hokkaido, Ishikawa-ken, Saitama) and removed the HHS Vulnerability Disclosure link. Revision updated to v3.3.3.SummaryDifference2%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedFooter revision tag updated to Revision: v3.3.2, replacing v3.3.1; no changes to study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check31 days agoChange DetectedPublications section wording updated to 'automatically filled from PubMed' and the revision tag changed from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check39 days agoChange DetectedRemoval of the government funding lapse notice from the page. The study information remains unchanged.SummaryDifference0.3%

- Check53 days agoChange DetectedNo significant updates were detected to the study record; only minor textual or layout adjustments may be present. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check81 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference3%

Stay in the know with updates to Olpasiran Study: Clinical Trial for Lipoprotein(a) Reduction
Enter your email address, and we'll notify you when there's something new on the Olpasiran Study: Clinical Trial for Lipoprotein(a) Reduction page.